Skip to content

iontophoresis versus prolotherapy

A Randomized Controlled placebo study of Dextrose iontophoresis versus Dextrose prolotherapy in case of knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201510001286134
Enrollment
60
Registered
2015-09-29
Start date
2015-02-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases osteoarthrities

Interventions

group A
group B
group c

Sponsors

faculty of physical therapy, kaferelshiek university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (a) moderate or moderate to severe knee OA (grade II or III according to the radiological classification of knee OA defined by Kellgren and Lawrence. (b) age between 45-65 years old

Exclusion criteria

Exclusion criteria: (a) severe OA (grade IV according to the Kellgren¿Lawrence system of classification). (b) history of rheumatologic or inflammatory diseases; (c) received oral or systemic corticosteroids during the 2 weeks prior to treatment; (d) received an intra-articular injection of hyaluronic acid agents during the previous month; (e) poorly controlled diabetes mellitus with fasting blood sugar greater than 11.1 mmol/L; (f) history of anticoagulation therapy; (g) history of prior total knee replacement surgery.

Design outcomes

Primary

MeasureTime frame
Knee ROM ,pain,stiffness and functional abilities

Secondary

MeasureTime frame
walking ability (walking 6 M and then measure pain)

Countries

Egypt

Contacts

Public Contactamal fawzy

dean faculty of physical therapy, kaferelshiek university

dramalfawzy6@gmail.com00201223819707

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026